Exploration and structure–activity relationship research of benzenesulfonamide derivatives as potent TRPV4 inhibitors for treating acute lung injury
Bioorganic Chemistry · 2024
DOI: 10.1016/j.bioorg.2024.107396 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2024. Verfasst von Mengyuan Wang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Research, Northwestern Polytechnical University, Xi'an 710072, China. Hauptthemen laut MEDLINE: TRPV Cation Channels, Acute Lung Injury, Sulfonamides, Benzenesulfonamides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences Initiative for Innovative Medicine, Key Research and Development Projects of Shaanxi Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
RN-9893, a TRPV4 antagonist identified by Renovis Inc., showcased notable inhibition of TRPV4 channels. This research involved synthesizing and evaluating three series of RN-9893 analogues for their TRPV4 inhibitory efficacy. Notably, compounds 1b and 1f displayed a 2.9 to 4.5-fold increase in inhibitory potency against TRPV4 (IC50 = 0.71 ± 0.21 μM and 0.46 ± 0.08 μM, respectively) in vitro, in comparison to RN-9893 (IC50 = 2.07 ± 0.90 μM). Both compounds also significantly outperformed RN-9893 in TRPV4 current inhibition rates (87.6 % and 83.2 % at 10 μM, against RN-9893's 49.4 %). For the first time, these RN-9893 analogues were profiled in an in vivo mouse model, where intraperitoneal injections of 1b or 1f at 10 mg/kg notably mitigated symptoms of acute lung injury induced by lipopolysaccharide (LPS). These outcomes indicate that compounds 1b and 1f are promising candidates for acute lung injury treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medical Research, Northwestern Polytechnical University, Xi'an 710072, China.
- Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China; Department of Pharmaceutical Chemistry, School of Pharmacy, Hebei Medical University, Sh…
- National Engineering Research Center for Strategic Drugs, Beijing Institute of Pharmacology and Toxicology Institution, Beijing 100850, China.
- Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
- MindRank AI Ltd., Hangzhou 310000, China.
- Institute of Medical Research, Northwestern Polytechnical University, Xi'an 710072, China. Electronic address: xjchen@nwpu.edu.
Förderung
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine
- Key Research and Development Projects of Shaanxi Province
- National Natural Science Foundation of China
- State Key Laboratory of Toxicology and Medical Countermeasures
Zitieren
APA
Wang, M., Zhang, Y., Cai, X., Yang, S., Sun, S., Zhou, S., Lv, W., Du, N., Li, Y., Ma, C., Ren, K., Liu, M., Tang, B., Wang, A., Chen, X., Li, P., Lv, K., & Zheng, Z. (2024). Exploration and structure–activity relationship research of benzenesulfonamide derivatives as potent TRPV4 inhibitors for treating acute lung injury. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2024.107396
Vancouver
Wang M, Zhang Y, Cai X, Yang S, Sun S, Zhou S, et al. Exploration and structure–activity relationship research of benzenesulfonamide derivatives as potent TRPV4 inhibitors for treating acute lung injury. Bioorganic Chemistry. 2024. doi:10.1016/j.bioorg.2024.107396
BibTeX
@article{Wang2024,
author = {Wang, Mengyuan and Zhang, Yuehao and Cai, Xu and Yang, Shangze and Sun, Shiyang and Zhou, Sheng and Lv, Weizhen and Du, Na and Li, Yan and Ma, Chao and Ren, Kexin and Liu, Mingliang and Tang, Bowen and Wang, Apeng and Chen, Xingjuan and Li, Pengyun and Lv, Kai and Zheng, Zhibing},
title = {Exploration and structure–activity relationship research of benzenesulfonamide derivatives as potent TRPV4 inhibitors for treating acute lung injury},
journal = {Bioorganic Chemistry},
year = {2024},
doi = {10.1016/j.bioorg.2024.107396}
}
EUVIMED